InsidersTradesSigma
Total declarations
Company
▲ Purchases (5 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by Traylor Margie L., Director. Officer active across 1 companies, notably Augmedix, Inc.. In total, 5 disclosures have been logged. Total volume traded: €25k. The latest transaction was disclosed on 26 May 2022 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations5 total
€13,4767,305 shares@ €1.844854.3% of flow
Common Stock
SEC:0001213900-22-030197:0·
Ideal exit: 20 Feb 2023 (T+270)
€2,891918 shares@ €3.149150.9% of flow
Common Stock
SEC:0001213900-21-062382·
Ideal exit: 23 Aug 2022 (T+270)
€2,891918 shares@ €3.149111.6% of flow
Common Stock
SEC:0001213900-21-062382:0·
Ideal exit: 23 Aug 2022 (T+270)
€2,786900 shares@ €3.095349.1% of flow
Common Stock
SEC:0001213900-21-060408·
Ideal exit: 23 Jul 2022 (T+270)
€2,786900 shares@ €3.095311.2% of flow
Common Stock
SEC:0001213900-21-060408:0·
Ideal exit: 23 Jul 2022 (T+270)
5 of 5 declarations
About Traylor Margie L.
Margie L. Traylor is a Board Member of Augmedix, Inc. In this role, she participates in the governance and strategy of the company. Her experience in the technology sector is valuable in guiding key decisions.
